cdk9 - Robuta Search

https://elifesciences.org/articles/06535/peer-reviews Peer review in Compensatory induction of MYC expression by sustained CDK9 inhibition via a... A new potent and selective CDK9 inhibitor induces the expression of the proto-oncogene MYC via a mechanism that depends on the bromodomain protein BRD4. https://elifesciences.org/articles/29736v1 CDK9-dependent RNA polymerase II pausing controls transcription initiation | eLife rna polymerase ii transcription initiation cdk9 dependent pausing https://www.thermofisher.com/antibody/product/CDK9-Antibody-Polyclonal/11705-1-AP CDK9 Polyclonal Antibody | Invitrogen (11705-1-AP) Detect CDK9 in WB, ICC/IF, IHC (P), ELISA, IP. Reacts with Rabbit, Mouse, Goat. Cited in 8 publications. Catalog # 11705-1-AP polyclonal antibody cdk9 invitrogen 11705 ap https://elifesciences.org/articles/06535/figures Figures and data in Compensatory induction of MYC expression by sustained CDK9 inhibition via a... A new potent and selective CDK9 inhibitor induces the expression of the proto-oncogene MYC via a mechanism that depends on the bromodomain protein BRD4. https://www.thermofisher.com/antibody/product/CDK9-Antibody-Polyclonal/61559 CDK9 Polyclonal Antibody (61559) Detect CDK9 in WB, ICC/IF, IHC (P), ELISA, IP. Reacts with Rabbit, Mouse, Goat. Catalog # 61559 polyclonal antibody cdk9 https://www.rcsb.org/structure/4BCI RCSB PDB - 4BCI: Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine... Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor https://www.thermofisher.com/antibody/product/CDK9-Antibody-clone-K-513-1-Monoclonal/MA5-14912 CDK9 Monoclonal Antibody (K.513.1) | Invitrogen (MA5-14912) Detect CDK9 in WB, ICC/IF, IHC (P), ELISA, IP. Reacts with Rabbit, Mouse, Goat. Cited in 3 publications. Catalog # MA5-14912 monoclonal antibody cdk9 513 invitrogen ma5 https://www.rcsb.org/structure/4BCJ RCSB PDB - 4BCJ: Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine... Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.01230/full Frontiers | CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current... Cyclin-Dependent Kinases (CDKs) are well-known reliable targets for cancer treatment being often deregulated. Among them, since the transcription-associated ... https://elifesciences.org/articles/29736/figures Figures and data in CDK9-dependent RNA polymerase II pausing controls transcription initiation |... CDK9 inhibition in human cells uncovers that Pol II pause duration regulates the frequency of productive transcription initiation. rna polymerase ii https://elifesciences.org/articles/44288 The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer... Targeting the CRL5 ubiquitin ligase complex in combination with CDK9 or MCL1 inhibition could combat innate and acquired resistance of cancer cells to... https://elifesciences.org/articles/29736/peer-reviews Peer review in CDK9-dependent RNA polymerase II pausing controls transcription initiation | eLife CDK9 inhibition in human cells uncovers that Pol II pause duration regulates the frequency of productive transcription initiation. rna polymerase ii